Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques

Juan C Frias1, Kevin Jon Williams, Edward A Fisher

  • 1Imaging Science Laboratories, Department of Radiology, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA.